ScrutarSign up free

MRK SEC Filings

SEC filings for MRK. Annual and quarterly reports, 8-K events,
Form 4 insider filings and 13D/G stake disclosures.

All10-K10-Q8-KForm 413D/GLast 12 months
FormFiledAccession
4Guindo ChirfiEVP, Access, Policy & CommsAug 13, 2026EDGAR
4Zachary JenniferEVP, General CounselAug 13, 2026EDGAR
4DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 12, 2026EDGAR
4DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 10, 2026EDGAR
4Maraldo David R.EVP & Pres. MMDAug 7, 2026EDGAR
4Williams David MichaelEVP,Chief Info&Digital OfficerAug 7, 2026EDGAR
4Guindo ChirfiEVP, Access, Policy & CommsAug 7, 2026EDGAR
10-QAug 7, 2026EDGAR
8-KAug 4, 2026EDGAR
8-KMay 28, 2026EDGAR
8-KMay 22, 2026EDGAR
4Smart Dalton E. IIISVP Fin. - Global ControllerMay 5, 2026EDGAR
4Maraldo David R.EVP & Pres. MMDMay 5, 2026EDGAR
10-QMay 4, 2026EDGAR
4Guindo ChirfiEVP, Access, Policy & CommsMay 1, 2026EDGAR
4Chattopadhyay SanatExe V-P & Pres. MMDMay 1, 2026EDGAR
4DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 1, 2026EDGAR
4Williams David MichaelEVP,Chief Info&Digital OfficerMay 1, 2026EDGAR
4Smart Dalton E. IIISVP Fin. - Global ControllerMay 1, 2026EDGAR
4Li Dean YExecutive VP & President, MRLMay 1, 2026EDGAR
4Zachary JenniferEVP, General CounselMay 1, 2026EDGAR
4Larson Betty DEVP, Chief HR OfficerMay 1, 2026EDGAR
4Litchfield CarolineEVP & CFOMay 1, 2026EDGAR
4Davis Robert MChairman, CEO & PresidentMay 1, 2026EDGAR
4Oosthuizen Johannes JacobusEVP, Oncology & Int?lMay 1, 2026EDGAR
SC 13GVanguard Capital ManagementApr 30, 2026EDGAR
8-KApr 30, 2026EDGAR
SC 13G/AamendedThe Vanguard GroupMar 27, 2026EDGAR
10-KFeb 24, 2026EDGAR
4Guindo ChirfiChief Marketing OfficerFeb 12, 2026EDGAR
4Li Dean YExecutive VP & President, MRLFeb 10, 2026EDGAR
4Guindo ChirfiChief Marketing OfficerFeb 9, 2026EDGAR
4Zachary JenniferEVP, General CounselFeb 9, 2026EDGAR
4Williams David MichaelEVP,Chief Info&Digital OfficerFeb 6, 2026EDGAR
4Smart Dalton E. IIISVP Fin. - Global ControllerFeb 6, 2026EDGAR
4Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 6, 2026EDGAR
4Litchfield CarolineEVP & CFOFeb 6, 2026EDGAR
4Li Dean YExecutive VP & President, MRLFeb 6, 2026EDGAR
4Guindo ChirfiChief Marketing OfficerFeb 6, 2026EDGAR
4DeLuca Richard R.EVP&Pres, Merck Animal HeallthFeb 6, 2026EDGAR
4Davis Robert MChairman, CEO & PresidentFeb 6, 2026EDGAR
8-KFeb 3, 2026EDGAR
4Zachary JenniferEVP, General CounselJan 28, 2026EDGAR
4Williams David MichaelEVP,Chief Info&Digital OfficerJan 28, 2026EDGAR
4Smart Dalton E. IIISVP Fin. - Global ControllerJan 28, 2026EDGAR
4Romanelli JosephPresident, Human Health Int?lJan 28, 2026EDGAR
4Oosthuizen Johannes JacobusPresident, U.S. MarketJan 28, 2026EDGAR
4Litchfield CarolineEVP & CFOJan 28, 2026EDGAR
4Li Dean YExecutive VP & President, MRLJan 28, 2026EDGAR
4Guindo ChirfiChief Marketing OfficerJan 28, 2026EDGAR
4DeLuca Richard R.EVP&Pres, Merck Animal HeallthJan 28, 2026EDGAR
4Davis Robert MChairman, CEO & PresidentJan 28, 2026EDGAR
4Chattopadhyay SanatExe V-P & Pres. MMDJan 28, 2026EDGAR
8-KDec 4, 2025EDGAR
4Downing Cristal NChief Comm. & Public Afrs OfcrNov 12, 2025EDGAR
10-QNov 5, 2025EDGAR
4Williams David MichaelEVP,Chief Info&Digital OfficerNov 4, 2025EDGAR
8-KOct 30, 2025EDGAR

Never miss a MRK filing.

Get an email when MRK files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Source: SEC EDGAR.